1. Home
  2. IVA vs BLMN Comparison

IVA vs BLMN Comparison

Compare IVA & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • BLMN
  • Stock Information
  • Founded
  • IVA 2011
  • BLMN 1988
  • Country
  • IVA France
  • BLMN United States
  • Employees
  • IVA N/A
  • BLMN N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • BLMN Restaurants
  • Sector
  • IVA Health Care
  • BLMN Consumer Discretionary
  • Exchange
  • IVA Nasdaq
  • BLMN Nasdaq
  • Market Cap
  • IVA 769.0M
  • BLMN 625.3M
  • IPO Year
  • IVA 2020
  • BLMN 2012
  • Fundamental
  • Price
  • IVA $5.27
  • BLMN $7.51
  • Analyst Decision
  • IVA Strong Buy
  • BLMN Hold
  • Analyst Count
  • IVA 7
  • BLMN 9
  • Target Price
  • IVA $16.57
  • BLMN $9.25
  • AVG Volume (30 Days)
  • IVA 211.2K
  • BLMN 1.8M
  • Earning Date
  • IVA 09-29-2025
  • BLMN 11-06-2025
  • Dividend Yield
  • IVA N/A
  • BLMN 7.99%
  • EPS Growth
  • IVA N/A
  • BLMN N/A
  • EPS
  • IVA N/A
  • BLMN N/A
  • Revenue
  • IVA $19,929,536.00
  • BLMN $3,933,993,000.00
  • Revenue This Year
  • IVA N/A
  • BLMN $1.43
  • Revenue Next Year
  • IVA N/A
  • BLMN $1.40
  • P/E Ratio
  • IVA N/A
  • BLMN N/A
  • Revenue Growth
  • IVA N/A
  • BLMN 2.47
  • 52 Week Low
  • IVA $2.11
  • BLMN $6.09
  • 52 Week High
  • IVA $7.98
  • BLMN $17.57
  • Technical
  • Relative Strength Index (RSI)
  • IVA 47.78
  • BLMN 50.46
  • Support Level
  • IVA $4.96
  • BLMN $7.56
  • Resistance Level
  • IVA $5.34
  • BLMN $8.17
  • Average True Range (ATR)
  • IVA 0.74
  • BLMN 0.35
  • MACD
  • IVA 0.07
  • BLMN 0.02
  • Stochastic Oscillator
  • IVA 23.86
  • BLMN 50.00

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

Share on Social Networks: